Aksenov Michael Y, Aksenova Marina V, Mactutus Charles F, Booze Rosemarie M
Program in Behavioral Neuroscience, University of South Carolina, SC 25908, USA.
Exp Neurol. 2009 Oct;219(2):586-90. doi: 10.1016/j.expneurol.2009.07.005. Epub 2009 Jul 15.
This study reports that the cysteine 22-->glycine 22 substitution in the HIV-1 Tat 1-86 B significantly attenuates its neurotoxicity. Consistent with previous studies, direct interactions of rat hippocampal cells with Tat 1-86 B were shown to cause dose-dependent and time-dependent neurotoxicity associated with activation of caspases from the mitochondrial apoptotic pathway. Despite the similar binding/uptake properties, Cys22 Tat 1-86 B failed to induce significant neurotoxicity and activation of caspases 9 and 3/7 in hippocampal primary cultures. Results of the study underscore the important role of cysteine-rich domain in mechanism of Tat-mediated neurotoxicity.
本研究报告称,HIV-1 Tat 1-86 B中半胱氨酸22突变为甘氨酸22会显著减弱其神经毒性。与先前的研究一致,大鼠海马细胞与Tat 1-86 B的直接相互作用显示会导致剂量和时间依赖性神经毒性,这与线粒体凋亡途径中半胱天冬酶的激活有关。尽管具有相似的结合/摄取特性,但Cys22 Tat 1-86 B在海马原代培养物中未能诱导明显的神经毒性以及半胱天冬酶9和3/7的激活。该研究结果强调了富含半胱氨酸结构域在Tat介导的神经毒性机制中的重要作用。